This opportunity is no longer accepting applications.
grant PAR-21-224

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

This grant opportunity invites small businesses to apply for funding to conduct exploratory clinical trials on investigational drugs, biologics, surgical therapies, or devices. These trials should help gather necessary data and justification for designing larger clinical studies. The diseases selected for study should align with the NINDS strategic plan and clinical research focus areas.

This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $1M
Award Amount: $1M

Dates

Opportunity Released: May 5, 2021
Open for Submission: May 5, 2021
Submission Deadline: September 5, 2024
Application Window Closes: September 5, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.